Related Experiment Video
Updated: Apr 3, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
22.2K
Immunotherapy for glioblastoma: concepts and challenges
Tobias Weiss1, Michael Weller, Patrick Roth
1Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Current Opinion in Neurology
|September 25, 2015
Summary
Immunotherapy shows promise for glioblastoma treatment, with vaccination and immune checkpoint inhibitors being advanced strategies. Further research is needed to optimize treatments and overcome challenges for better patient outcomes.
Area of Science:
- Oncology
- Immunology
- Neuro-oncology
Background:
- Immunotherapy is a rapidly developing treatment for glioblastoma.
- It aims to stimulate the patient's immune system to fight cancer.
Purpose of the Study:
- To review recent preclinical and clinical advancements in glioblastoma immunotherapy.
- To discuss the concepts, challenges, strengths, and weaknesses of current approaches.
Main Methods:
- Review of preclinical studies.
- Analysis of phase I and II clinical trials.
- Evaluation of immunotherapeutic strategies like vaccination and immune checkpoint inhibition.
Main Results:
- Immunotherapy is well-tolerated and induces antitumor immune responses in glioblastoma.
- Vaccination (e.g., EGFRvIII) and immune checkpoint inhibitors (e.g., CTLA-4, PD-1) are promising.
- Challenges include identifying new targets, patient selection, managing side effects, and integration with other therapies.
Conclusions:
- Immunotherapy offers target specificity, adaptability, and durability for glioblastoma.
- Preclinical and clinical results are encouraging, but optimization and further development are essential.
- Overcoming challenges is crucial for successful clinical implementation.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K